Founded Date:
1992-02-11
Last Funding Type:
Post-IPO Debt
Headquarters:
New York, New York, United States
Investors Number:
1.0
Technology:
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Employee Number:
101-250
Industry:
Early Drug Development
Estimated Revenue:
$10M to $50M
Last Funding Date:
2017-09-05
Funding Status:
IPO
Total Funding:
407231243.0